Henrik Arne Sprengel
Amministratore Delegato presso THCinol/CBDinol CanPharma GmbH
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
David Attwood | M | - |
THCinol/CBDinol CanPharma GmbH
THCinol/CBDinol CanPharma GmbH Pharmaceuticals: OtherHealth Technology Part of CanPharma GmbH /Jacker/, THCinol/CBDinol CanPharma GmbH is a German company that brings years of experience in the treatment with cannabinoids and necessary expertise to ensure a professional handling of medical cannabis. The company is based in Oranienburg, Germany. The company aims to fully unleash the potential of medical cannabis with a focus on the well-being of the patient. The company offers quality products, specialized information, and a CanPharma patient ID. The company was founded by Holger Sprengel and Henrik Arne Sprengel, with Henrik Arne Sprengel serving as CEO since incorporation. THCinol/CBDinol CanPharma was acquired by CanPharma GmbH /Jacker/ from Health House International Ltd. on November 16, 2022. | 3 anni |
Juan de Haro Arjona | M | - |
Global Group Kalapa SL
Global Group Kalapa SL Medical/Nursing ServicesHealth Services Global Group Kalapa SL is a research and production company. It is engaged in the research and production of cosmetics and pharmacy products of cannabinoids. The company was founded on November 18, 2014 and is headquartered in Gava, Spain. | 10 anni |
Stefan Jacker | M | - |
THCinol/CBDinol CanPharma GmbH
THCinol/CBDinol CanPharma GmbH Pharmaceuticals: OtherHealth Technology Part of CanPharma GmbH /Jacker/, THCinol/CBDinol CanPharma GmbH is a German company that brings years of experience in the treatment with cannabinoids and necessary expertise to ensure a professional handling of medical cannabis. The company is based in Oranienburg, Germany. The company aims to fully unleash the potential of medical cannabis with a focus on the well-being of the patient. The company offers quality products, specialized information, and a CanPharma patient ID. The company was founded by Holger Sprengel and Henrik Arne Sprengel, with Henrik Arne Sprengel serving as CEO since incorporation. THCinol/CBDinol CanPharma was acquired by CanPharma GmbH /Jacker/ from Health House International Ltd. on November 16, 2022. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Tony Samios | M | - | 2 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Australia | 2 | 50.00% |
Germania | 2 | 50.00% |
Spagna | 1 | 25.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Henrik Arne Sprengel
- Contatti personali